This study is currently not recruiting participants.

Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center: Identifying Patients at Risk and Simplifying ECG Monitoring

Investigating Risk Factors for Heart Rhythm Changes with Methadone

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to determine what factors put patients at risk for developing an abnormal finding on the electrocardiogram (ECG) called QT interval prolongation when taking methadone, a medicine that is known to cause this side effect.

Detailed description of study

The purpose of this study is to determine what factors put patients at risk for developing an abnormal finding on the electrocardiogram (ECG) called QT interval prolongation when taking methadone, a medicine that is known to cause this side effect.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Methadone-Induced QT Interval Prolongation
  • Age: 100 years or below
  • Gender: All

This study investigates the risk factors that may lead to QT interval prolongation, an abnormal finding on the electrocardiogram (ECG), in patients taking methadone. The QT interval is a measurement made on an ECG that reflects the time it takes for the heart's electrical system to reset after each heartbeat. Prolongation of the QT interval can be a side effect of methadone, a medication used for pain relief and opioid addiction treatment.

Participants in the study will undergo procedures to monitor their heart's electrical activity through ECGs while taking methadone. The study will assess various factors to determine their influence on the risk of developing QT interval prolongation.

  • Who can participate: Eligibility criteria include adults aged 18 and older who are currently taking methadone. Additional criteria may apply based on specific health conditions or medication use.
  • Study details: The study will monitor participants' heart electrical activity through ECGs while they are on methadone to assess factors influencing the risk of QT interval prolongation.
Updated on 19 Feb 2024. Study ID: 1608001774

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team